Advertisement

PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 14–14 | Cite as

Gender-neutral 9-valent HPV vaccine program cost effective

Meeting report
  • 2 Downloads

References

  1. 1.
    Olsen J, et al. Cost-Effectiveness of Gender-Neutral Nine-Valent HPV Vaccination in Denmark. 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PIN50, 10 Nov 2018. Available from: URL: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/87798?pdfid=56747
  2. 2.
    Pavelyev A, et al. Public Health and Economic Impact of Gender-Neutral Human Papillomavirus (HPV) Vaccination with the Nonavalent HPV Vaccine in Belgium (Wallonia Region) Using a Transmission Dynamic Model. 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PIN36, 10 Nov 2018. Available from: URL: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/88129?pdfid=56742

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations